At a glance
ClinicalIndex Comparison RecordN/ACompleted· 496 enrolled
Drug / intervention
Tomosynthesis +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
In Brief
A clinical study evaluating Tomosynthesis and Conventional for Breast Cancer. Completed, enrolled 496 participants across 1 site.
Detailed Summary
The primary hypothesis to be tested is: The detection of breast cancer will be increased with tomosynthesis (3D) imaging
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsHologic, Inc.
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
Primary CompletionJun 2011
First PostedAug 2012
Study CompletionOct 2012
TodayJul 2026
First PostedAug 20, 2012
Enrollment StartNov 1, 2007
Primary CompletionJun 1, 2011
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 13.9 years ago
Interventions
Tomosynthesisdevice
The mean glandular radiation dose for each image will be approximately 145 millirads (mrad) for a standard size breast (4.2 cm compressed breast thickness).
Conventionaldevice
conventional (2D) imaging (standard mammography)